Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Effective May 1st, 2020
BCSD Portugal, 23 July 2021
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Presented by the Hénokiens Association and the Château du Clos Lucé
Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.